Compare SAM & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SAM | ATRC |
|---|---|---|
| Founded | 1984 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 1996 | 2005 |
| Metric | SAM | ATRC |
|---|---|---|
| Price | $181.88 | $35.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 7 |
| Target Price | ★ $233.70 | $51.17 |
| AVG Volume (30 Days) | 284.3K | ★ 1.0M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 95.45 | 74.74 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,964,994,000.00 | $201,630,000.00 |
| Revenue This Year | $1.02 | $15.27 |
| Revenue Next Year | $1.31 | $12.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $158.68 | $25.36 |
| 52 Week High | $264.46 | $43.18 |
| Indicator | SAM | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 52.53 | 72.64 |
| Support Level | $170.14 | $35.47 |
| Resistance Level | $188.80 | $38.42 |
| Average True Range (ATR) | 7.50 | 1.58 |
| MACD | -0.02 | 0.43 |
| Stochastic Oscillator | 59.40 | 92.85 |
Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates almost all sales in the US.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.